Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Damora Therapeutics, a biotech company focused on hematologic disorders, announced inducement stock option grants totaling 57,500 shares to two newly hired, non-executive employees. These grants were approved under Nasdaq Listing Rule 5635(c)(4) and vest over four years, aiming to attract talent as the company advances its pipeline targeting myelop…